The main office of represented VC is situated in the Newton. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Mediphase Venture Partners, startups are often financed by Skyline Ventures, New Leaf Venture Partners, Sprout Group. The meaningful sponsors for the fund in investment in the same round are New Leaf Venture Partners, Sprout Group, Skyline Ventures. In the next rounds fund is usually obtained by OrbiMed, New Leaf Venture Partners, 5AM Ventures.
We can highlight the next thriving fund investment areas, such as Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Relypsa, Serenex, PatientKeeper. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Besides them, we counted 2 critical employees of this fund in our database.
The top amount of exits for fund were in 2014. The top activity for fund was in 2007. Opposing the other organizations, this Mediphase Venture Partners works on 4 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 1 percentage points less often commits exit comparing to other companies.
Related Funds
Funds with similar focus
Fund Name | Location |
Castik Capital Partners | Bayern, Germany, Munich |
China Taiping Insurance | China, Hong Kong, Hong Kong Island |
DECLATEX | - |
IncSyn Business Incubation Ltd. | - |
Indies Capital Partners | Central, Central Region, Singapore |
Linde Material Handling | Aschaffenburg, Bayern, Germany |
McCombs Enterprises | San Antonio, Texas, United States |
Modalku | East Java, Indonesia, Kebon |
Outerwall | Bellevue, United States, Washington |
Savox Investments | - |
SG INCUBATE | Fukuoka, Fukuoka Prefecture, Japan |
Shanghai Huaming Intelligent Terminal Equipment | China, Shanghai |
Sigma Square Capital | Beijing, Beijing, China |
Standout Capital | Stockholm, Stockholm County, Sweden |
Tong Yang Venture Capital | Seoul, Seoul-t'ukpyolsi, South Korea |
University of Cape Town | Gauteng, NA - South Africa, South Africa |
VE Partners | Amsterdam, Noord-Holland, The Netherlands |
Vestech International | - |
Xiamen ITG Group | China, Fujian, Xiamen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Relypsa | $80M | 14 Aug 2012 | Redwood City, California, United States | ||
Relypsa | $70M | 08 Aug 2011 | Redwood City, California, United States | ||
Relypsa | $70M | 13 Sep 2010 | Redwood City, California, United States | ||
Tetraphase Pharmaceuticals | $45M | 01 Jun 2010 | Massachusetts, United States | ||
Tetraphase Pharmaceuticals | $25M | 22 Sep 2009 | Massachusetts, United States | ||
Tetraphase Pharmaceuticals | $15M | 07 Aug 2008 | Massachusetts, United States | ||
Concert Pharmaceuticals | $37M | 30 Apr 2008 | Massachusetts, United States | ||
Relypsa | $33M | 29 Oct 2007 | Redwood City, California, United States | ||
$7M | 27 Mar 2007 | Portland, Oregon, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Relypsa | $80M | 14 Aug 2012 | Redwood City, California, United States | ||
Relypsa | $70M | 08 Aug 2011 | Redwood City, California, United States | ||
Relypsa | $70M | 13 Sep 2010 | Redwood City, California, United States | ||
Tetraphase Pharmaceuticals | $45M | 01 Jun 2010 | Massachusetts, United States | ||
Tetraphase Pharmaceuticals | $25M | 22 Sep 2009 | Massachusetts, United States | ||
Tetraphase Pharmaceuticals | $15M | 07 Aug 2008 | Massachusetts, United States | ||
Concert Pharmaceuticals | $37M | 30 Apr 2008 | Massachusetts, United States | ||
Relypsa | $33M | 29 Oct 2007 | Redwood City, California, United States | ||
$7M | 27 Mar 2007 | Portland, Oregon, United States |